Related Experiment Videos

HER2 in prostate cancer--a viable target or innocent bystander?

Journal of the National Cancer Institute

|December 7, 2000

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Development and validation of circulating tumour cell enumeration (Epic Sciences) as a prognostic biomarker in men with metastatic castration-resistant prostate cancer.

European journal of cancer (Oxford, England : 1990)·2021

Circulating tumour cell increase as a biomarker of disease progression in metastatic castration-resistant prostate cancer patients with low baseline CTC counts.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Periprostatic adipose inflammation is associated with high-grade prostate cancer.

Prostate cancer and prostatic diseases·2017

Androgen receptor mutations in patients with castration-resistant prostate cancer treated with apalutamide.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.

Clinical pharmacology and therapeutics·2017

A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel.

Annals of oncology : official journal of the European Society for Medical Oncology·2015

See all related articles